Cite
CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia
MLA
Biondi, M., et al. CXCR4-Modified CD33.CAR-CIK with Enhanced Bone Marrow Homing in Acute Myeloid Leukemia. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..390da425da896ff97929f293b3ab72c3&authtype=sso&custid=ns315887.
APA
Biondi, M., Cerina, B., Tomasoni, C., Dotti, G., Tettamanti, S., Biondi, A., Pievani, A., & Serafini, M. (2022). CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia.
Chicago
Biondi, M, B Cerina, C Tomasoni, G Dotti, S Tettamanti, A Biondi, A Pievani, and M Serafini. 2022. “CXCR4-Modified CD33.CAR-CIK with Enhanced Bone Marrow Homing in Acute Myeloid Leukemia,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..390da425da896ff97929f293b3ab72c3&authtype=sso&custid=ns315887.